My Personal Biomedical Research Feed - Ralph Turchiano, CEO Alchepharma
Publishes | Weekly | Episodes | 291 | Founded | 5 years ago |
---|---|---|---|---|---|
Number of Listeners | Categories | Health & FitnessAlternative Health |
A recent 8-week, randomized, double-blind, placebo-controlled pilot study explored the effects of the probiotic strain Weizmannia coagulans BC99 on symptoms of anxiety and depression. The trial involved 79 participants who received either 3 grams of ... more
The present study demonstrates that green tea extract and ginger supplementation, individually and in combination, enhanced endurance performance, metabolic efficiency, and thermal perception in recreationally active males under normothermic and cold... more
A major scientific review looked at the best available evidence on apple cider vinegar (ACV) and its effects on body weight. Researchers combined the results from 9 different studies that included adults who were overweight, obese, or had type 2 diab... more
A recent randomized, double-blind, placebo-controlled study published in the journal Nutrients investigated the effects of Cistanche deserticola (CD) supplementation on muscle strength and recovery. The eight-week trial involved 48 male participants,... more
People also subscribe to these shows.
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #151 | |
Apple Podcasts | #221 |
Listeners, social reach, demographics and more for this podcast.
Listeners per Episode | Gender Skew | Location | |||
---|---|---|---|---|---|
Interests | Professions | Age Range | |||
Household Income | Social Media Reach |
Rephonic provides a wide range of podcast stats for ClinicalNews.Org. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to ClinicalNews.Org and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for ClinicalNews.Org, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for ClinicalNews.Org, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers ClinicalNews.Org has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with ClinicalNews.Org:
ClinicalNews.Org launched 5 years ago and published 291 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for ClinicalNews.Org from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of ClinicalNews.Org. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.